Cognizant Seeks Dismissal of Infosys' Antitrust Counterclaims in Ongoing Legal Battle

The ongoing legal dispute between Cognizant Technology Solutions and Infosys has taken a new turn. On April 14, 2025, Cognizant filed a motion in a U.S. court, asking for the dismissal of Infosys’ antitrust counterclaims. Infosys has accused Cognizant of monopolistic behavior and anti-competitive practices, alleging that the company has used its market dominance to block competition in the healthcare software sector. However, Cognizant argues that these claims are not substantiated by sufficient evidence and are based on speculative assertions. This legal battle has now been raging for over eight months, showing no signs of letting up.

Cognizant’s motion to dismiss is the latest chapter in this fierce legal conflict, where both companies have exchanged sharp allegations, each trying to prove the other’s business practices are harmful. Infosys had initially accused Cognizant of using monopoly power to prevent its healthcare platform, Helix, from competing with Cognizant’s TriZetto Software Group. In response, Cognizant dismissed these claims as vague and unsupported by real evidence.

Key Points of the Dispute

Monopolization Allegations: Infosys has accused Cognizant of inflating prices and blocking new market entrants to maintain a dominant position in the healthcare software sector. However, Cognizant argues that these claims lack the required factual backing.
Market Share Dispute: Cognizant’s legal team points out that their market share of 65% is below the 70% threshold often considered necessary for a monopolization claim under U.S. antitrust law. This makes Infosys’ accusations difficult to substantiate.
Hiring Practices Under Fire: Infosys also claims that Cognizant’s recruitment of high-level executives from Infosys—most notably CEO Ravi Kumar S.—was a predatory tactic aimed at weakening the competitor. Cognizant, however, asserts that hiring talent from competitors is standard industry practice and does not constitute illegal conduct.
Trade Secrets Allegations: The conflict originally started in August 2024, when Cognizant accused Infosys of stealing trade secrets related to its TriZetto platform. Infosys’ counterclaim, filed in January 2025, focuses on alleged antitrust violations and exclusionary practices designed to stifle competition.

What Undercode Says:

The ongoing legal clash between Infosys and Cognizant highlights some of the more complex and nuanced issues within the tech industry’s competitive landscape, particularly in the healthcare software market. From an antitrust perspective, the argument centers on whether Cognizant’s actions have been anticompetitive and whether the allegations of monopolization are valid.

One of the key issues here is the accusation that Cognizant is inflating prices to preserve its market position. While this claim might resonate with consumers in highly concentrated industries, the factual evidence provided by Infosys so far seems weak. Antitrust law requires clear evidence of market manipulation and harm to consumers, which Infosys has yet to substantiate with concrete data.

Furthermore, the dispute over market share is also critical. While Infosys argues that Cognizant’s 65% market share gives it undue influence, it’s important to note that U.S. antitrust law typically considers a market share of 70% or more as indicative of monopolistic power. This legal threshold is significant, as it demonstrates that not all market dominances automatically translate into anticompetitive behavior. Cognizant’s defense—asserting that their market share does not meet this threshold—is grounded in these legal standards.

The hiring of executives, particularly the recruitment of Ravi Kumar S. from Infosys, has also become a contentious issue. Infosys frames this as a tactic of “poaching” to weaken its operations, but Cognizant’s defense suggests that executive turnover and recruitment between competitors are common in the tech industry. This highlights the difference between what might be perceived as aggressive competition and what is simply a part of normal industry practices. The fact that such cases are often difficult to prove in court shows that legal boundaries between ethical hiring and anti-competitive practices are often blurry.

In terms of the broader implications for the industry, this dispute underscores the ongoing tension between innovation, market dominance, and competition. As more companies operate in highly concentrated sectors, antitrust cases like this will likely continue to be a focal point for regulators. With the increasing focus on data privacy, intellectual property, and competitive behavior, the outcome of this legal battle could set important precedents for how tech giants interact within regulated industries.

Fact Checker Results:

Monopolization Claims: Infosys’ claims are unlikely to pass legal muster given that Cognizant’s market share of 65% falls below the 70% threshold commonly associated with monopolistic power.
Inflated Pricing: There’s insufficient evidence presented to prove that Cognizant has artificially inflated prices in a way that harms the market or consumers.
Executive Poaching: Recruitment of high-level executives, including Ravi Kumar S., does not appear to constitute a violation of antitrust law and is consistent with industry practices.